Converge is at the forefront of integrating Generative AI with biological data, transforming drug discovery and development. By harnessing the power of Large Language Models (LLMs) trained on the unique syntax of biological systems, we empower biotech and pharmaceutical companies to predict biological outcomes, contextualize them with deeper insights, and generate novel molecular candidates.